Fundraising Fox
Hummsa Biotech
1 known investors
Find your way into Hummsa Biotech
Sign up to see every warm intro you have to Hummsa Biotech
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Hummsa Biotech team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Hummsa Biotech develops oral small molecule therapeutics targeting chronic metabolic diseases through multi-targeted approaches, aiming to shift treatment from reactive to preventive and regenerative care. The company prioritizes affordability and accessibility across global markets.
Founders & leadership
TM
Timo Müller
Investors · 1
Frequently asked questions
- What does Hummsa Biotech do?
- Hummsa Biotech develops oral small molecule therapeutics targeting chronic metabolic diseases through multi-targeted approaches, aiming to shift treatment from reactive to preventive and regenerative care. The company prioritizes affordability and accessibility across global markets.
- Who founded Hummsa Biotech?
- Hummsa Biotech was founded by Timo Müller.
- Who are Hummsa Biotech's investors?
- Hummsa Biotech's investors include Randev Ventures Family Office.